Most clinical trials run in Canada failed to take basic steps toward transparency, analysis finds; Antibiotics sales of food-producing animals drop in Europe

Taking stock of the drug industry, from the lab to the medicine chest

November 27, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

J. Scott Applewhite/AP STAT+ | Most clinical trials run in Canada failed to take basic steps toward transparency, analysis finds A new analysis, published in Facets, a medical journal, underscores ongoing concerns about clinical trial transparency. By Ed Silverman STAT+ | Sales of antibiotics for food-producing animals dropped by more than half in Europe over the past decade Antibiotics given to food-producing livestock to prevent and treat disease can contribute to antibiotic-resistant bacteria in humans. By Ed Silverman STAT+ | With new trial data, a blockbuster therapy from Sanofi, Regeneron could find an even bigger market The study's results could lead to an expansion of Dupixent's approval to COPD, widening the market for the blockbuster therapy even further. By Andrew Joseph Christine Kao/STAT STAT+ | With biotech in a slump, the industry's job market is upside down Bioscience job postings have dropped from around 19,000 in February 2022 to 10,000 in October 2023, according to one estimate. By Jonathan Wosen and Damian Garde

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser